• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Ralfinamide mesylate Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5758435

MBS5758435 is an inhibitor targeting Ralfinamide mesylate. Ralfinamide mesylate is an orally available Na+ channel blocker. More details

Please Inquire
Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Ralfinamide mesylate, Inhibitor
Full Product Name
Ralfinamide mesylate
Product Synonym Names
FCE-26742A (mesylate)
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
398.45
Solubility
<1mg/ml refers to the product slightly soluble or insoluble
Formula
C18H23FN2O5S
SMILES
CC(NCc1ccc(OCc2ccccc2F)cc1)C(N)=O.CS(=O)(=O)O
CAS Number
202825-45-4
Target & IC50
Sodium channel

Product Categories/Family for Ralfinamide mesylate, inhibitor

Membrane transporter/Ion channel; Sodium Channel

Structure of Ralfinamide mesylate, inhibitor

Ralfinamide mesylate Inhibitor – Cat# MBS5758435

Product References and Citations for Ralfinamide mesylate, inhibitor

Liang X, Yu G, Su R. Effects of ralfinamide in models of nerve injury and chemotherapy-induced neuropathic pain[J]. European journal of pharmacology, 2018, 823:27-34.
Liang X, Yu G, Su R. Effects of ralfinamide in models of nerve injury and chemotherapy-induced neuropathic pain[J]. European journal of pharmacology, 2018, 823:27-34.
Bayes M, Rabasseda X, Prous J R. Gateways to Clinical Trials[J]. Methods & Findings in Experimental & Clinical Pharmacology, 2008, 30(4):313.
Bayes M, Rabasseda X, Prous J R. Gateways to Clinical Trials[J]. Methods & Findings in Experimental & Clinical Pharmacology, 2008, 30(4):313.

Other Notes

Small volumes of Ralfinamide mesylate, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000